本页面由Tiger Trade Technology Pte. Ltd.提供服务

Inari Medical, Inc.

79.97
0.0000
成交量:- -
成交额:1.89亿
市值:46.97亿
市盈率:-59.05
高:79.97
开:79.97
低:79.97
收:79.97
52周最高:79.99
52周最低:36.73
股本:5,873.66万
流通股本:5,385.95万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.3543
每股收益(LYR):-0.0288
净资产收益率:-17.72%
总资产收益率:-3.21%
市净率:10.80
市盈率(LYR):-2,775.10

数据加载中...

2025/02/19

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2025/02/19

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/02/19

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/02/19

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/02/19

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/02/19

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/02/19

重要事件披露

Form 8-K - Current report
2025/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/06

重要事件披露

Form 8-K - Current report
2024/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/28

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/28

重要事件披露

Form 8-K - Current report
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]